Peripheral Neuropathy Trial, Recruiting NCT04699734 Sponsor: University of Aarhus Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT04699734
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older.
  • People who have been assessed as probably having diabetic nerve damage, confirmed using a specific set of medical criteria that requires all three of the following to be present: symptoms of sensory nerve problems, reduced feeling in the hands or feet, and reduced ankle reflexes.
  • People who have had definite or probable nerve pain for at least the last 6 months.
  • People whose average pain level over the past week has been rated higher than 4 out of 10 on a pain scale.

Who may not be able to join:

  • People who have other causes of pain in the same area, or other pain that cannot be clearly separated from the nerve pain.
  • People who are unable to understand and speak Danish.
  • People who are unable to cooperate with the trial requirements.
  • People taking Warfarin or other blood-thinning or similar medications that would make a nerve block injection unsafe (confirm with trial site).
  • People who have an active infection in the area where the injection would be given.
  • People with a known allergy to lidocaine (a local anaesthetic).
  • People who are pregnant or breastfeeding. Women of childbearing age would need to show a negative pregnancy test or confirm use of contraception.
  • People who have had severe psychiatric illness, such as severe depression, within the last 6 months.
  • People with a current problem with alcohol or drug misuse.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ellen L Schaldemose, MD, Danish Pain Research Center, Aarhus University

Phone: +45 93501942

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 September 2020
Est. completion
31 December 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Indication of pain relieved extremity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov